Pinverin Application Trial to Reduce Bowel Uptake of FDG (Fluorodeoxyglucose)
NCT02173964
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
58
Enrollment
OTHER
Sponsor class
Conditions
Cancer
Interventions
DRUG:
pinaverium bromide
DRUG:
water
Sponsor
Seoul National University Hospital